Charles River Laboratories International's EBITDA per Share for the
three
months ended in Dec. 2023 was $6.29.
During the past 12 months, Charles River Laboratories International's average EBITDA Per Share Growth Rate was 4.40% per year.
During the past 3 years, the average EBITDA Per Share Growth Rate was 9.70% per year.
During the past 5 years, the average EBITDA Per Share Growth Rate was 15.20% per year.
During the past 10 years, the average EBITDA Per Share Growth Rate was 15.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Charles River Laboratories International was 19.30% per year. The lowest was -15.80% per year. And the median was 9.70% per year.
Competitive Comparison
For the Diagnostics & Research subindustry, Charles River Laboratories International's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Charles River Laboratories International 5-Year EBITDA Growth Rate Distribution
For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's 5-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Charles River Laboratories International's 5-Year EBITDA Growth Rate falls into.
Charles River Laboratories International 5-Year EBITDA Growth Rate Calculation
This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
Charles River Laboratories International (NYSE:CRL) 5-Year EBITDA Growth Rate Explanation
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.
Charles River Laboratories International 5-Year EBITDA Growth Rate Related Terms
Thank you for viewing the detailed overview of Charles River Laboratories International's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
Charles River Laboratories International (Charles River Laboratories International) Business Description
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CRL has been successfully added to your